Genentech
GAZYVA
Manufacturer:
Genentech
Name:
GAZYVA
HCPCS Code Descriptor:
Injection, obinutuzumab, 10 mg
Category:
J Code
HCPCS:
J9301
NDC(s):
50242-0070-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
GAZYVA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9301 is aligned to the drug GAZYVA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/15
HCPCS Effective Date:
1/1/15
HCPCS Short Description:
Obinutuzumab inj
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/GAZYVA-Billing-Coding-for-Chronic-Lymphoid-Leukemia.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation